Synthekine teams up with Merck to test breakthrough lung cancer combo
Novartis’ remibrutinib bags positive CHMP opinion for chronic urticaria
Combination therapy cuts death Risk in advanced prostate cancer: PEACE-3 trial
FDA nod to Boehringer Ingelheim’s first-line therapy for HER2-mutant lung cancer
Eli Lilly’s orforglipron outshines oral semaglutide in landmark diabetes trial
Thermo Fisher launches genetic test to personalize transplant drug dosing
Eli Lilly and Incyte score key win for teens with severe alopecia areata in Europe
Merck’s KEYTRUDA shows significant survival boost in platinum-resistant ovarian cancer
Pfizer and Astellas report groundbreaking results in muscle-invasive bladder cancer trial
Lupin tops world pharma and all Indian sectors in S&P ESG rankings
The deal was executed via a merger of Novartis’ wholly owned subsidiary, Ajax Acquisition Sub, Inc., into Avidity
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
.jpg?v=1772312979)
